Exenatide extended-release: Once a week
How GLP-1-Based Medications Work GLP-1-based therapies - including compounded versions - work by enhancing the bodys natural appetite and glucose regulation processes: Appetite Signaling: Helps you feel full with less food Insulin Modulation: Encourages insulin release to manage post-meal blood sugar Gastric Delay: Slows stomach emptying, which can support smaller portion sizes These effects make GLP-1 medications a promising option for those looking to support long-term health with provider guidance
The most well-known examples, apart from pioglitazone, are fenofibrate, pemafibrate, seladelpar, elafibranor and lanifibranor, which have been studied in various trials regarding their effect on liver inflammation and fibrosis, without particular success, with the exception of lanifibranor, a pan-PPAR agonist, which was shown in a phase 2b RCT (NATIVE-NCT03008070) to improve ballooning and inflammation, without worsening of fibrosis
Yet, other studies show a muscle atrophy-protecting effect (8, 9, 11)